These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8051388)

  • 1. Splanchnic and systemic hemodynamics in early abstinence and after ethanol administration in non-cirrhotic alcoholic patients.
    Silva G; Fluxá F; Bresky G; Backhouse C; Palma M; Ruiz M; Hirsch S; Iturriaga H
    J Hepatol; 1994 Apr; 20(4):494-9. PubMed ID: 8051388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
    Navasa M; Chesta J; Bosch J; Rodés J
    Gastroenterology; 1989 Apr; 96(4):1110-8. PubMed ID: 2925055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
    Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
    Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis.
    Møller S; Brinch K; Henriksen JH; Becker U
    J Hepatol; 1997 May; 26(5):1026-33. PubMed ID: 9186833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
    García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
    J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nifedipine on hepatic venous pressure gradient and portal vein blood flow in patients with cirrhosis.
    Ota K; Shijo H; Kokawa H; Kubara K; Kim T; Akiyoshi N; Yokoyama M; Okumura M
    J Gastroenterol Hepatol; 1995; 10(2):198-204. PubMed ID: 7787167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis.
    Luca A; García-Pagán JC; Bosch J; Feu F; Caballería J; Groszmann RJ; Rodés J
    Gastroenterology; 1997 Apr; 112(4):1284-9. PubMed ID: 9098014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis.
    Merkel C; Gatta A; Bolognesi M; Finucci G; Battaglia G; Angeli P; Zuin R
    Dig Dis Sci; 1988 Sep; 33(9):1103-9. PubMed ID: 3409797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic evaluation of molsidomine: a vasodilator with antianginal properties in patients with alcoholic cirrhosis.
    Vinel JP; Monnin JL; Combis JM; Calés P; Desmorat H; Pascal JP
    Hepatology; 1990 Feb; 11(2):239-42. PubMed ID: 2307402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicardipine infusion improved hepatic function but failed to reduce hepatic venous pressure gradient in patients with cirrhosis.
    Iwao T; Toyonaga A; Ikegami M; Sugawara H; Sumino M; Takagi K; Oho K; Sakaki M; Ohkubo K; Inoue R
    Am J Gastroenterol; 1992 Mar; 87(3):326-31. PubMed ID: 1539567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
    Merkel C; Finucci G; Zuin R; Bazzerla G; Bolognesi M; Sacerdoti D; Gatta A
    J Hepatol; 1987 Apr; 4(2):174-80. PubMed ID: 3584925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
    Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
    Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure.
    Taourel P; Blanc P; Dauzat M; Chabre M; Pradel J; Gallix B; Larrey D; Bruel JM
    Hepatology; 1998 Oct; 28(4):932-6. PubMed ID: 9755228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study.
    Ludwig D; Schädel S; Brüning A; Schiefer B; Stange EF
    Dig Dis Sci; 2000 May; 45(5):1019-27. PubMed ID: 10795771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: possible role of serotonergic mechanisms in portal hypertension.
    Hadengue A; Lee SS; Moreau R; Braillon A; Lebrec D
    Hepatology; 1987; 7(4):644-7. PubMed ID: 3610044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters.
    Bolognesi M; Sacerdoti D; Mescoli C; Bombonato G; Cillo U; Merenda R; Giacomelli L; Merkel C; Rugge M; Gatta A
    Scand J Gastroenterol; 2007 Feb; 42(2):256-62. PubMed ID: 17327946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The organ extraction and splanchnic haemodynamic effects of octreotide in cirrhotic patients.
    Ottesen LH; Flyvbjerg A; Møller S; Bendtsen F
    Aliment Pharmacol Ther; 1998 Jul; 12(7):657-65. PubMed ID: 9701530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of portal pressure by chronic administration of isosorbide dinitrate in patients with cirrhosis: effects on systemic and splanchnic hemodynamics and liver function.
    Ikegami M; Toyonaga A; Tanikawa K
    Am J Gastroenterol; 1992 Sep; 87(9):1160-4. PubMed ID: 1519573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic and functional hepatic effects of isosorbide-5-monitrate in cirrhotic patients with portal hypertension].
    Silva G; Fluxá F; Ruiz M; Bresky G; Barrientos C; Backhouse C; Palma M; Iturriaga H
    Rev Med Chil; 1993 Aug; 121(8):889-96. PubMed ID: 8296096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis.
    Kakumitsu S; Shijo H; Yokoyama M; Kim T; Akiyoshi N; Ota K; Kubara K; Okumura M; Inoue K
    Hepatology; 1998 Feb; 27(2):377-82. PubMed ID: 9462634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.